Rajendra Kumar Singh

Professor of Developmental, Molecular and Chemical Biology at Tufts University School of Medicine.

Developing gene therapy for various forms of blindness including age related macular degeneration, retinitis pigmentosa, diabetic retinopathy, uveitis. Developing viral and non-viral gene and protein delivery vectors for the retina and cornea. Scientific Founder of Hemera Biosciences Inc. Developing gene therapies for dry and wet AMD. Inventor of HMR59. Acquired by Janssen/ JNJ in December 2020